Katherine Bracamontes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Katherine Bracamontes has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Bikash Bhattarai
Valleywise Health Medical Center
1 shared publicationChelsea Stewart
University of California, Los Angeles
1 shared publication- John Farley
Common Spirit
1 shared publication Robert Garfield
Department of Obstetrics and Gynecology, University of Arizona College of Medicine, Phoenix, AZ, United States
1 shared publicationSierra M. Treiman
Creighton Ob/Gyn Residency - Phoenix Campus
1 shared publication
Latest Publications
- 1 November 2023
- Published by Bentham Science Publishers Ltd. in Current Women s Health Reviews
- Vol. 19 (4) , 1
Progesterone and Treatment for Preterm Birth: Past, Present and Future
Preterm birth (PTB) remains a leading cause of neonatal morbidity and mortality in the United States and worldwide. Efforts to predict and delay preterm birth have been largely unsuccessful thus far. This paper seeks to illuminate the history and relevant discoveries regarding the role of progesterone in the prevention of PTB, which includes maintaining quiescence of the myometrium and counteracting cervical ripening. We will review the outcomes and methodologies of recent clinical trials, which have led to debate over the efficacy of progesterone in delaying PTB among at-risk women. The aim of this paper is to explore the historical and scientific basis for progestin treatments in the prevention of PTB, briefly discuss the results of recent clinical trials, and suggest direction for future research.
- 1 November 2023
- Published by Bentham Science Publishers Ltd. in Current Women s Health Reviews
- Vol. 19 (4) , 1
Progesterone and Treatment for Preterm Birth: Past, Present and Future
Preterm birth (PTB) remains a leading cause of neonatal morbidity and mortality in the United States and worldwide. Efforts to predict and delay preterm birth have been largely unsuccessful thus far. This paper seeks to illuminate the history and relevant discoveries regarding the role of progesterone in the prevention of PTB, which includes maintaining quiescence of the myometrium and counteracting cervical ripening. We will review the outcomes and methodologies of recent clinical trials, which have led to debate over the efficacy of progesterone in delaying PTB among at-risk women. The aim of this paper is to explore the historical and scientific basis for progestin treatments in the prevention of PTB, briefly discuss the results of recent clinical trials, and suggest direction for future research.
- Open Access
- 15 September 2023
- Published by Elsevier in Gynecologic Oncology Reports
- Vol. 48, S22
41 COVID-19 vaccination in cancer patients receiving chemotherapy: does vaccination increase the risk of hypersensitivity reactions?
- 15 September 2023
- Published by Elsevier in Gynecologic Oncology Reports
- Vol. 48, S22
Open Access41 COVID-19 vaccination in cancer patients receiving chemotherapy: does vaccination increase the risk of hypersensitivity reactions?